Agency Information Collection Activities: Proposed Collection; Comment Request, 65611-65612 [E8-26247]

Download as PDF dwashington3 on PRODPC61 with NOTICES Federal Register / Vol. 73, No. 214 / Tuesday, November 4, 2008 / Notices and from 8:30 a.m. to 3:30 p.m. on December 16, 2008, at the Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, Maryland 20814. The meeting will be open to the public; however, seating is limited and preregistration is encouraged (see below). SUPPLEMENTARY INFORMATION: Pursuant to Public Law 109–129, 42 U.S.C. 274k (section 379 of the Public Health Service Act, as amended) the ACBSCT was established to advise the Secretary of HHS and the Administrator, HRSA, on matters related to the activities of the C.W. Bill Young Cell Transplantation Program (Program) and the National Cord Blood Inventory (NCBI) Program. ACBSCT is composed of up to 25 members, including the Chair, serving as Special Government Employees. The current membership includes representatives of marrow donor centers and marrow transplant centers; representatives of cord blood banks and participating birthing hospitals; recipients of a bone marrow transplant; recipients of a cord blood transplant; persons who require such transplants; family members of such a recipient or family members of a patient who has requested the assistance of the Program in searching for an unrelated donor of bone marrow or cord blood; persons with expertise in bone marrow and cord blood transplantation; persons with expertise in typing, matching, and transplant outcome data analysis; persons with expertise in the social sciences; basic scientists with expertise in the biology of adult stem cells; ethicists; hematology and transfusion medicine researchers with expertise in adult blood stem cells; persons with expertise in cord blood processing; and members of the general public. The Council will hear reports from four of the ACBSCT Work Groups: Cord Blood Accreditation Organization and Recognition Process, Need for Public Funding for Required Data Documentation, Scientific Factors Necessary to Define a Cord Blood Unit as High Quality, and Program Confidentiality/Policies for Cord Blood Donors. The Council also will hear presentations and discussions on Product Labeling; the Blood Stem Cell Transplant Physician Shortage; CMS Evaluation of Coverage for Myelodysplastic Syndromes; Models for Cord Blood Donor Recruitment; and the Center for International Blood and Marrow Transplant Research update on several research activities. The draft meeting agenda and a registration form will be available on November 17, 2008, on the HRSA’s Program Web site at http:// VerDate Aug<31>2005 15:23 Nov 03, 2008 Jkt 217001 bloodcell.transplant.hrsa.gov/ABOUT/ Advisory_Council/index.html. The completed registration form should be submitted by facsimile to Professional and Scientific Associates (PSA), the logistical support contractor for the meeting, at fax number (703) 234–1701 ATTN: Lilly Cho. Registration can also be completed electronically at https:// www.team-psa.com/dot/fall2008/ acbsct/. Individuals without access to the Internet who wish to register may call Lilly Cho with PSA at (703) 234– 1733. Individuals who plan to attend the meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the ACBSCT Executive Secretary, Remy Aronoff, in advance of the meeting. Mr. Aronoff may be reached by telephone at 301–443–3264, e-mail: Remy.Aronoff@hrsa.hhs.gov or in writing at the address provided below. Management and support services for ACBSCT functions are provided by the Division of Transplantation, Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Parklawn Building, Room 12C–06, Rockville, Maryland 20857; telephone number 301–443–7577. After the presentations and Council discussions, members of the public will have an opportunity to provide comments. Because of the Council’s full agenda and the timeframe in which to cover the agenda topics, public comment will be limited. All public comments will be included in the record of the ACBSCT meeting. Meeting summary notes will be made available on the HRSA’s Program Web site at http://bloodcell.transplant.hrsa.gov/ ABOUT/Advisory_Council/index.html. Dated: October 28, 2008. Elizabeth M. Duke, Administrator. [FR Doc. E8–26272 Filed 11–3–08; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection; Comment Request In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 65611 Services Administration (SAMHSA) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer on (240) 276– 1243. Comments are invited on: (a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Proposed Project: Notification of Intent to Use Schedule III, IV, or V Opioid Drugs for the Maintenance and Detoxification Treatment of Opiate Addiction Under 21 U.S.C. 823(g)(2) (OMB No. 0930–0234)—Revision The Drug Addiction Treatment Act of 2000 (‘‘DATA,’’ Pub. L. 106–310) amended the Controlled Substances Act (21 U.S.C. 823(g)(2)) to permit practitioners (physicians) to seek and obtain waivers to prescribe certain approved narcotic treatment drugs for the treatment of opiate addiction. The legislation sets eligibility requirements and certification requirements as well as an interagency notification review process for physicians who seek waivers. The legislation was amended in 2005 to eliminate the patient limit for physicians in group practices, and in 2006, to permit certain physicians to treat up to 100 patients. To implement these provisions, SAMHSA developed a notification form (SMA–167) that facilitates the submission and review of notifications. The form provides the information necessary to determine whether practitioners (i.e., independent physicians) meet the qualifications for waivers set forth under the new law. Use of this form will enable physicians to know they have provided all information needed to determine whether practitioners are eligible for a waiver. However, there is no prohibition on use of other means to provide requisite information. The Secretary will convey notification information and determinations to the Drug Enforcement Administration (DEA), which will assign an identification number to E:\FR\FM\04NON1.SGM 04NON1 65612 Federal Register / Vol. 73, No. 214 / Tuesday, November 4, 2008 / Notices qualifying practitioners; this number will be included in the practitioner’s registration under 21 U.S.C. 823(f). Practitioners may use the form for three types of notification: (a) New, (b) immediate, and (c) to notify of their intent to treat up to 100 patients. Under ‘‘new’’ notifications, practitioners may make their initial waiver requests to SAMHSA. ‘‘Immediate’’ notifications inform SAMHSA and the Attorney General of a practitioner’s intent to prescribe immediately to facilitate the treatment of an individual (one) patient under 21 U.S.C. 823(g)(2)(E)(ii). Finally, the form may be used by physicians with waivers to certify their need and intent to treat up to 100 patients. The form collects data on the following items: Practitioner name; state medical license number and DEA registration number; address of primary location, telephone and fax numbers; email address; name and address of group practice; group practice employer identification number; names and DEA registration numbers of group practitioners; purpose of notification new, immediate, or renewal; certification of qualifying criteria for treatment and management of opiate dependent patients; certification of capacity to refer patients for appropriate counseling and other appropriate ancillary services; certification of maximum patient load, certification to use only those drug products that meet the criteria in the law. The form also notifies practitioners of Privacy Act considerations, and permits practitioners to expressly consent to disclose limited information to the Number of respondents Purpose of submission SAMHSA Buprenorphine Physician Locator. Since July 2002, SAMHSA has received over 17,000 notifications and has certified almost 16,000 physicians. Eighty-one percent of the notifications were submitted by mail or by facsimile, with approximately twenty percent submitted through the Web based online system. Approximately 60 percent of the certified physicians have consented to disclosure on the SAMHSA Buprenorphine Physician Locator. Respondents may submit the form electronically, through a dedicated Web page that SAMHSA will establish for the purpose, as well as via U.S. mail. The following table summarizes the estimated annual burden for the use of this form. Responses per respondent Burden per response (hr.) Total burden (hrs) Initial Application for Waiver ............................................................................ Notification to Prescribe Immediately .............................................................. Notice to Treat up to 100 patients ................................................................... 1,500 50 500 1 1 1 .083 .083 .040 125 4 20 Total .......................................................................................................... 2,050 ........................ ........................ 149 Send comments to Summer King, SAMHSA Reports Clearance Officer, Room 7–1044, One Choke Cherry Road, Rockville, MD 20857 and e-mail her a copy at summer.king@samhsa.hhs.gov. Written comments should be received within 60 days of this notice. Dated: October 28, 2008. Elaine Parry, Acting Director, Office of Program Services. [FR Doc. E8–26247 Filed 11–3–08; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF THE INTERIOR Office of the Secretary Performance Review Board appointments Office of the Secretary, Interior. Notice of appointments. AGENCY: dwashington3 on PRODPC61 with NOTICES ACTION: SUMMARY: This notice provides the names of individuals who have been appointed to serve as members of the 2008 Department of the Interior Performance Review Board. DATES: These appointments are effective upon publication in the Federal Register. FOR FURTHER INFORMATION CONTACT: Sharlyn Grigsby, Director, Office of Human Resources, Office of the Secretary, Department of the Interior, VerDate Aug<31>2005 15:23 Nov 03, 2008 Jkt 217001 1849 C Street, NW., Washington, DC 20240, Telephone Number: (202) 208– 6761. Dated: October 22, 2008. Sharlyn A. Grigsby, Director, Office of Human Resources. 2008 Performance Review Board Eligibles ABEITA, ETHEL J, DIRECTOR, OTR ACHTERBERG, DAVID G., DIR, SECURITY, SAFETY & LAW ENFORCEMENT ALBERTS, JASON P., ASSOC SOLICITOR-MINERAL RESOURCES ANSPACH, ALLEN J., REGIONAL DIRECTOR ARHA, KAUSHALENDRA, DEPUTY ASSISTANT SECRETARY ARROYO, BRYAN, ASST DIRENDANGERED SPECIES ASHE, DANIEL M., FISH AND WILDLIFE ADVISOR BAGLIN, CHRISTINE S., DIR, OFC OF POLICY ANALYSIS BAKER, KAREN D., ASSOC DIR FOR ADMIN POLICY & SERVICES BARCHENGER, ERVIN J., REGIONAL DIRECTOR-MRCC ASSOCIATE DIRECTOR, AVIATION BATHRICK, MARK L., MANAGMENT BAYANI, THERESA WALSH, PROGRAM DIRECTOR FOR BECK, RICHARD T., DIRECTOR, OFFICE OF PLANNING & BECKMANN, DARRYL H., DEP COM, POLICY, ADMIN & BUDGET PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 BENNETT, ROBERT A., STATE DIRECTOR BHAGOWALIA, SANJEEV NMN, CHIEF INFORMATION OFFICER BISSON, HENRI R., DEPUTY DIRECTOR BLACK, MICHAEL S., REGIONAL DIRECTOR-GREAT PLAINS BLACKWELL, EDITH R., DEP ASSOC SOL-INDIAN AFFAIRS BLANCHARD, MARY JOSIE, DEPUTY DIRECTOR BOGERT, L. MICHAEL, COUNSELOR TO THE SECRETARY BOURGEOIS, DOUGLAS J., DIRECTOR, NATIONAL BUSINESS CENTER BRADLEY, OMAR, REGIONAL DIRECTOR BREECE, CHARLES E., ATTORNEY— ADVISOR (GENERAL) BROUN, LAURENCE I., DIRECTOR, OFFICE OF EMERGENCY MGMT BROWN, LAURA B., DEP ASSOC SOL—LAND & WATER RES BROWN, ROBERT E., ASSOC DIR FOR ADMIN AND BUDGET BURCH, MELVIN E., REGIONAL FIDUCIARY TRUST BURCKMAN, JAMES N., HUMAN RESOURCES PROJECT LEADER BURKS, MARIA A., EXECUTIVE DIRECTOR CHIEF, OFFICE OF BUDGET & BURZYK, CARLA M., PERFORMANCE BUTLER, MITCHELL J., DEPUTY ASSISTANT SECRETARY— E:\FR\FM\04NON1.SGM 04NON1

Agencies

[Federal Register Volume 73, Number 214 (Tuesday, November 4, 2008)]
[Notices]
[Pages 65611-65612]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-26247]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Proposed Collection; 
Comment Request

    In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction 
Act of 1995 concerning opportunity for public comment on proposed 
collections of information, the Substance Abuse and Mental Health 
Services Administration (SAMHSA) will publish periodic summaries of 
proposed projects. To request more information on the proposed projects 
or to obtain a copy of the information collection plans, call the 
SAMHSA Reports Clearance Officer on (240) 276-1243.
    Comments are invited on: (a) Whether the proposed collections of 
information are necessary for the proper performance of the functions 
of the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology.

Proposed Project: Notification of Intent to Use Schedule III, IV, or V 
Opioid Drugs for the Maintenance and Detoxification Treatment of Opiate 
Addiction Under 21 U.S.C. 823(g)(2) (OMB No. 0930-0234)--Revision

    The Drug Addiction Treatment Act of 2000 (``DATA,'' Pub. L. 106-
310) amended the Controlled Substances Act (21 U.S.C. 823(g)(2)) to 
permit practitioners (physicians) to seek and obtain waivers to 
prescribe certain approved narcotic treatment drugs for the treatment 
of opiate addiction. The legislation sets eligibility requirements and 
certification requirements as well as an interagency notification 
review process for physicians who seek waivers. The legislation was 
amended in 2005 to eliminate the patient limit for physicians in group 
practices, and in 2006, to permit certain physicians to treat up to 100 
patients.
    To implement these provisions, SAMHSA developed a notification form 
(SMA-167) that facilitates the submission and review of notifications. 
The form provides the information necessary to determine whether 
practitioners (i.e., independent physicians) meet the qualifications 
for waivers set forth under the new law. Use of this form will enable 
physicians to know they have provided all information needed to 
determine whether practitioners are eligible for a waiver.
    However, there is no prohibition on use of other means to provide 
requisite information. The Secretary will convey notification 
information and determinations to the Drug Enforcement Administration 
(DEA), which will assign an identification number to

[[Page 65612]]

qualifying practitioners; this number will be included in the 
practitioner's registration under 21 U.S.C. 823(f).
    Practitioners may use the form for three types of notification: (a) 
New, (b) immediate, and (c) to notify of their intent to treat up to 
100 patients. Under ``new'' notifications, practitioners may make their 
initial waiver requests to SAMHSA. ``Immediate'' notifications inform 
SAMHSA and the Attorney General of a practitioner's intent to prescribe 
immediately to facilitate the treatment of an individual (one) patient 
under 21 U.S.C. 823(g)(2)(E)(ii). Finally, the form may be used by 
physicians with waivers to certify their need and intent to treat up to 
100 patients.
    The form collects data on the following items: Practitioner name; 
state medical license number and DEA registration number; address of 
primary location, telephone and fax numbers; e-mail address; name and 
address of group practice; group practice employer identification 
number; names and DEA registration numbers of group practitioners; 
purpose of notification new, immediate, or renewal; certification of 
qualifying criteria for treatment and management of opiate dependent 
patients; certification of capacity to refer patients for appropriate 
counseling and other appropriate ancillary services; certification of 
maximum patient load, certification to use only those drug products 
that meet the criteria in the law. The form also notifies practitioners 
of Privacy Act considerations, and permits practitioners to expressly 
consent to disclose limited information to the SAMHSA Buprenorphine 
Physician Locator.
    Since July 2002, SAMHSA has received over 17,000 notifications and 
has certified almost 16,000 physicians. Eighty-one percent of the 
notifications were submitted by mail or by facsimile, with 
approximately twenty percent submitted through the Web based online 
system. Approximately 60 percent of the certified physicians have 
consented to disclosure on the SAMHSA Buprenorphine Physician Locator.
    Respondents may submit the form electronically, through a dedicated 
Web page that SAMHSA will establish for the purpose, as well as via 
U.S. mail.
    The following table summarizes the estimated annual burden for the 
use of this form.

----------------------------------------------------------------------------------------------------------------
                                                     Number of     Responses per    Burden per     Total burden
              Purpose of submission                 respondents     respondent    response (hr.)       (hrs)
----------------------------------------------------------------------------------------------------------------
Initial Application for Waiver..................           1,500               1            .083             125
Notification to Prescribe Immediately...........              50               1            .083               4
Notice to Treat up to 100 patients..............             500               1            .040              20
                                                 ---------------------------------------------------------------
    Total.......................................           2,050  ..............  ..............             149
----------------------------------------------------------------------------------------------------------------

    Send comments to Summer King, SAMHSA Reports Clearance Officer, 
Room 7-1044, One Choke Cherry Road, Rockville, MD 20857 and e-mail her 
a copy at summer.king@samhsa.hhs.gov. Written comments should be 
received within 60 days of this notice.

    Dated: October 28, 2008.
Elaine Parry,
Acting Director, Office of Program Services.
[FR Doc. E8-26247 Filed 11-3-08; 8:45 am]
BILLING CODE 4162-20-P